Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,949
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,732
Class I recallsReasonable probability of serious health consequences
24,263
Class II recallsTemporary or medically reversible health consequences
2,873
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,071 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/foods-alive-recalls-organic-moringa-leaf-powder-because-possible-health-riskPublished September 4, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,458 recalls have been announced year to date.
  • Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1

Showing 481–500 of 18,483 recalls

FDA Recall Ongoing 2026 recordClass II

exchange select, Menthol -Cough Suppressant Oral Anesthetic, Honey Lemon Flavor Cough Drops, 30-count bag, Manufactured for Your Military Exchanges By: Medical Group Care, LLC., 1035 Collier Center Way, STE 5, Naples, FL, Made in China, NDC 83698-580-30, UPC: 614299398870.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

SLMD Benzoyl Peroxide Acne Lotion, Benzoyl Peroxide 2.5%, a) 0.7 fl. oz - 21 mL and b) 1.5 fl. oz. - 44mL bottles, SANDRA LEE MD., Distributed by Skin PS Brands, Culver City, CA 90232.

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, Sandra Lee MD, Distributed by Skin PS Brands, Culver City, CA90232.

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 FL OZ/60ml spray bottle; DIST BY HYDROPEPTIDE LLC, ISSAQUAH, WA 98027

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

FHF Farmhouse Fresh, Midnight Clearing, NIGHT LOTION, 2.5% BENZOYL PEROXIDE ACNE TREATMENT, OTC a) 0.5 fl. oz./15ml; and b)1 fl. oz./30ml tubes; Made in the USA for FarmHouse Fresh, 8797 CR 858 McKinney, Texas

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

by Cipla USA, Inc.

Reason
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-411-02

by Cipla USA, Inc.

Reason
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

by Cipla USA, Inc.

Reason
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Published
April 22, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.

by GE Healthcare Ireland Limited

Reason
Presence of particulate matter
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.

by GE Healthcare Ireland Limited

Reason
Presence of particulate matter
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91

by Viatris, Inc.

Reason
Failed Dissolution Specifications
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0

by Preferred Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01

by Fagron Compounding Services

Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01

by Fagron Compounding Services

Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01

by Fagron Compounding Services

Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02

by Fagron Compounding Services

Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02

by Fagron Compounding Services

Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30.

by Fresenius Kabi USA, LLC

Reason
Lack of Assurance of Sterility
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50.

by Fresenius Kabi USA, LLC

Reason
Lack of Assurance of Sterility
Published
April 15, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60.

by Fresenius Kabi USA, LLC

Reason
Lack of Assurance of Sterility
Published
April 15, 2026
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.